Recently, it has been shown that the expression of CD9 is increased in PCa of patients who suffer from disease recurrence in 5 years, indicating the role of CD9 in the progression of recurrent advanced PCa (69). The gene discussed is CD9; the disease is posterior cortical atrophy.